Due to that CGRP is often used as a marker of nociceptive nerves and is the most abundant neuropeptide in trigeminal nerves [20, 21], we think that the neurogenic CGRP may enhance the malignant phenotypes of cancer cell and lead to PNI and LNM. The gene discussed is NPS; the disease is cancer.